Cancer Weekly
Susan Hasty, Publisher
Table of Contents . . . October 21st, 1996
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Cancer Vaccines - Phase I/II Trial for MGV Cancer Vaccine Begins
Cancer Vaccines - Transloading Tumor Cells with a Foreign Peptide Generates A Potent Immune Response
Cancer Vaccines - Trial Approval Received for Ovarex Vaccine in Canada
Antisense Technology - Patent Received on Antisense Inhibitor of C-raf Kinase
Breast Cancer (Diagnostics) - FDA Status Update Announced for Cancer Test
Breast Cancer (Diagnostics) - Technology Offered for Improved Detection of Early Stage Cancer
Breast Cancer (Genetics) - Testing Availability for Cancer in Persons of Ashkenazi Jewish Descent
Breast Cancer (Screening) - Women with Breast Implants Can Receive Non-Surgical Biopsy
Cachexia - Compounds Developed To Treat Cancer Muscle Wasting
Carcinogenesis - Newly Discovered Gene Halts Cell Division and May Have Cancer Link
Colorectal Cancer (Diagnostics) - CEA-Scan Detection Agent Cleared for Sale in Europe
Colorectal Cancer (Diagnostics) - Clinical Trials of Blood-Based Cancer Test Begin
Esophageal Cancer (Therapy) - Availability of Photofrin for Injection Announced
Genetic Testing - Education Critical in Genetic Susceptibility Testing
Genetic Testing - Organization Calls for Strong Protections for Genetic Information Use
HBV Vaccines - Contract Awarded for Hepatitis B Adult Vaccine
Human Herpesvirus 8 (Screening) - Virus Appears Sexually Transmitted and Associated with Kaposi's Sarcoma
Human Papillomavirus Type 18 (Prognosis) - HPV-18 Is Independent Prognostic Factor in Cervical Cancer
Industry News (Acquisitions) - Anticancer Drug Acquired - To Be Sold in U.S. and Canada
Industry News (Clinical Trials) - CEP-2563 Phase I Cancer Study Launched
Industry News (Funding) - Grants Received To Scale-Up Manufacturing of Products
Industry News (Funding) - SBIR Development Grant Received for Improved Tumor Agent
Industry News (Genomics) - 40,000 Human Genes Discovered Using SBH Technology Reported
Industry News (Joint Venture) - MASDA Technology Used for Mutation Detection in Colorectal Cancer
Industry News (Joint Venture) - MRI Technique Commercialized for Breast Cancer Diagnosis and Therapy
Industry News (Licensing) - FAS Gene Licensed as Component of System
Industry News (Licensing) - Oncogene Ras Processing Inhibitors Licensed
Industry News (Patents and Technologies) - Allowance Notice Received for Licensed Cancer Technology
Industry News (Patents and Technologies) - Allowance Received for Reformulation Technology
Industry News (Patents and Technologies) - Notice of Allowance Received on U.S. Patent
International (Europe) - Young Europeans Unaware of Hepatitis B Risk
Leukemia (Treatment) - Hycamtin Achieves Promising Results in Patients
Pancreatic Cancer (Therapy) - FDA Approves Stehlin Foundation Anticancer Drug
Smoking Issues - Joint Research Initiative Tests Effects of LungCheck
Tumor Markers - ASCO Issues New Guidelines on Tests
Disease Associations - "Risk Factors and Outcome from Invasive Aspergillosis (IA)."
Epidemiology - "A Prospective Case-Control Study of Diarrhea in Cancer Patients."
Opportunistic Infection - "Antibiotic-Lock Technique for the Prevention of Gram-Positive Central Venous Catheter-Related Infections in Neutropenic Cancer Patients."
Opportunistic Infections - "Intra-arterial Catheters for Cancer Chemotherapy (IACC): Low Infection Rate Associated with Aseptic Insertions."
Opportunistic Infections - "Validation of a Clinical Prediction Model for Surgical Site Infection after Oncology Operations."
Prophylaxis - "Empirical Antibiotic Therapy for Bacteremic Pneumonia in Neutropenic Cancer Patients (NCP)."
Prophylaxis (Aspergillosis) - "Randomized Multicentre Trial of 1mg/kg (LD) Versus 4 mg/kg (HD) Liposomal Amphotericin B (Ambisome) (LAB) in the Treatment of Invasive
Vaccine Development (EBV) - "Recombinant EBV gp350 as a Subunit Vaccine Candidate to Prevent EBV-Related Disease."
Bile Duct Carcinoma - "MUC1-Specific Targeting Immunotherapy with Bispecific Antibodies: Inhibition of Xenografted Human Bile Duct Carcinoma Growth."
Cancer Gene Therapy - "Active Site-Directed Double Mutants of Dihydrofolate Reductase."
Cancer Gene Therapy - "Gastrin Gene Expression Is Required for the Proliferation and Tumorigenicity of Human Colon Cancer Cells."
Cancer Gene Therapy - "Noninvasive Imaging of Herpes Virus Thymidine Kinase Gene Transfer and Expression: A Potential Method for Monitoring Clinical Gene Therapy."
Cancer Vaccines - "Results of a Phase I Trial of a Recombinant Vaccinia Virus That Expresses Carcinoembryonic Antigen in Patients with Advanced Colorectal Cancer."
Drug Resistance - "Reversal by Hyaluronidase of Adhesion-Dependent Multicellular Drug Resistance in Mammary Carcinoma Cells."
Hepatocellular Carcinoma - "Flow Cytometric DNA Analysis of Cirrhotic Liver Cells in Patients with Hepatocellular Carcinoma Can Provide a New Prognostic Factor."
Immunology - "Predominance of TH1 Response in Tumor Bearing Mice and Cancer Patients Treated with AS101."
Melanoma - "Independent Prognostic Importance of Vascular Invasion in Nodular Melanomas."
Ovarian Cancer - "Intraperitoneal Radioimmunotherapy of Ovarian Cancer with Lutetium-177-CC49."
Prostate Cancer - "Delayed/Salvage Radiation Therapy in Patients with Elevated Prostate Specific Antigen Levels after Radical Prostatectomy - A Long Term Follow-Up."
Therapy - "Effect of Cyclin D1 Overexpression on Drug Sensitivity in a Human Fibrosarcoma Cell Line."
Therapy - "Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of Paclitaxel."
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
